Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

75.39 +1.80 (+2.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 586,045
Open 73.68
Bid (Size) 75.00 (1,000)
Ask (Size) 78.79 (500)
Prev. Close 73.59
Today's Range 73.54 - 75.67
52wk Range 69.58 - 99.39
Shares Outstanding 24,422,240
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
2 Value Stocks on Our Watchlist and 1 We Find Risky
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t... 
Via StockStory
News headline image
2 Reasons to Like ANIP (and 1 Not So Much)
ANI Pharmaceuticals currently trades at $76.15 per share and has shown little upside over the past six months, posting a middling return of 3%. The stock als... 
Via StockStory
Topics Supply Chain

Performance

YTD
-3.9%
-3.9%
1 Month
-0.8%
-0.8%
3 Month
-6.4%
-6.4%
6 Month
+1.6%
+1.6%
1 Year
-22.7%
-22.7%

More News

Read More
News headline image
1 Russell 2000 Stock to Target This Week and 2 We Brush Off
Via StockStory
News headline image
ANI Pharmaceuticals (ANIP) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
ANI Pharmaceuticals (NASDAQ:ANIP) Tumbles on Weak Guidance Despite Q2 EPS Beat ↗
Via Chartmill
News headline image
The Top 5 Analyst Questions From ANI Pharmaceuticals’s Q2 Earnings Call
Via StockStory
Topics Earnings
News headline image
Winners And Losers Of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) Vs The Rest Of The Generic Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
ANIP Q2 Deep Dive: Rare Disease Expansion Drives Growth Amid Guidance Recalibration
Via StockStory
News headline image
ANI Pharmaceuticals Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
ANI Pharmaceuticals’s (NASDAQ:ANIP) Q2 CY2026 Sales Beat Estimates But Stock Drops On Weak Guidance
Via StockStory
Topics Earnings
News headline image
ANI Pharmaceuticals (ANIP) Q2 Earnings: What To Expect
Via StockStory
Topics Artificial Intelligence
News headline image
1 Healthcare Stock Worth Your Attention and 2 We Question
Via StockStory
News headline image
Spotting Winners: Amneal (NASDAQ:AMRX) And Generic Pharmaceuticals Stocks In Q1
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Generic Pharmaceuticals Stocks Q1 Highlights: Viatris (NASDAQ:VTRS)
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
Via StockStory
News headline image
2 Reasons to Watch ANIP and 1 to Stay Cautious
Via StockStory
News headline image
2 Small-Cap Stocks Worth Investigating and 1 We Brush Off
Via StockStory
News headline image
ANI Pharmaceuticals' CFO Sold $285,000 in Stock After a 32% Run ↗
Via The Motley Fool
Topics Economy Regulatory Compliance
News headline image
2 Value Stocks for Long-Term Investors and 1 We Avoid
Via StockStory
News headline image
ANI Pharmaceuticals CFO Sells $240,000 in Stock After a 42% Cortrophin Surge ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
3 of Wall Street’s Favorite Stocks to Target This Week
Via StockStory
News headline image
2 Cash-Producing Stocks to Research Further and 1 Facing Challenges
Via StockStory
News headline image
Ani (ANIP) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
2 Growth Stocks with Explosive Upside and 1 We Avoid
Via StockStory

Frequently Asked Questions

Is ANI Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, ANI Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does ANI Pharmaceuticals, Inc. - Common Stock trade on?
ANI Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ANI Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for ANI Pharmaceuticals, Inc. - Common Stock is ANIP on the Nasdaq Stock Market
What is the current price of ANI Pharmaceuticals, Inc. - Common Stock?
The current price of ANI Pharmaceuticals, Inc. - Common Stock is 75.39
When was ANI Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of ANI Pharmaceuticals, Inc. - Common Stock was at 09/17/26 04:00 PM ET
What is the market capitalization of ANI Pharmaceuticals, Inc. - Common Stock?
The market capitalization of ANI Pharmaceuticals, Inc. - Common Stock is 1.84B
How many shares of ANI Pharmaceuticals, Inc. - Common Stock are outstanding?
ANI Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.